Neoplasms, Colorectal Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01722162Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal CancerTreatment
NCT01677884Intra-arterial Hepatic Bevacizumab and Systemic ChemotherapyTreatment
NCT00677144Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal CancerTreatment
NCT01765582A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Participants With Metastatic Colorectal Cancer (STEAM)Treatment